These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33417072)

  • 41. Semi-mechanistic kidney model incorporating physiologically-relevant fluid reabsorption and transporter-mediated renal reabsorption: pharmacokinetics of γ-hydroxybutyric acid and L-lactate in rats.
    Dave RA; Morris ME
    J Pharmacokinet Pharmacodyn; 2015 Oct; 42(5):497-513. PubMed ID: 26341876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal clearance of gamma-hydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy.
    Morris ME; Hu K; Wang Q
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1194-202. PubMed ID: 15722403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Variety of symptoms after drug use of gamma-hydroxybutyric acid (GHB)].
    Galldiks N; Kadow I; Bechdolf A; Fink GR; Klosterkötter J; Kuhn J
    Fortschr Neurol Psychiatr; 2011 Jan; 79(1):21-5. PubMed ID: 21154180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
    Keating GM
    Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
    Abanades S; Farré M; Segura M; Pichini S; Barral D; Pacifici R; Pellegrini M; Fonseca F; Langohr K; De La Torre R
    Ann N Y Acad Sci; 2006 Aug; 1074():559-76. PubMed ID: 17105953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alcohol perturbed locomotor behavior, metabolism, and pharmacokinetics of gamma-hydroxybutyric acid in rats.
    Kim M; Oh S; Kim S; Ji M; Choi B; Bae JW; Lee YS; Paik MJ; Lee S
    Biomed Pharmacother; 2023 Aug; 164():114992. PubMed ID: 37301134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
    Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
    Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
    Caputo F; Vignoli T; Tarli C; Domenicali M; Zoli G; Bernardi M; Addolorato G
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26959045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. γ-Hydroxybutyric acid (GHB) is not an agonist of extrasynaptic GABAA receptors.
    Connelly WM; Errington AC; Crunelli V
    PLoS One; 2013; 8(11):e79062. PubMed ID: 24244421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review.
    Dufayet L; Bargel S; Bonnet A; Boukerma AK; Chevallier C; Evrard M; Guillotin S; Loeuillet E; Paradis C; Pouget AM; Reynoard J; Vaucel JA
    Regul Toxicol Pharmacol; 2023 Aug; 142():105435. PubMed ID: 37343712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results.
    Andresen H; Aydin BE; Mueller A; Iwersen-Bergmann S
    Drug Test Anal; 2011 Sep; 3(9):560-8. PubMed ID: 21381220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.
    Vijay N; Morris ME
    J Pharm Sci; 2014 Oct; 103(10):3310-5. PubMed ID: 25174723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. γ-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptor-transporter inhibition therapy for treatment in GHB overdose.
    Morse BL; Vijay N; Morris ME
    Mol Pharmacol; 2012 Aug; 82(2):226-35. PubMed ID: 22561075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of L-lactate and D-mannitol on gamma-hydroxybutyrate toxicokinetics and toxicodynamics in rats.
    Wang Q; Wang X; Morris ME
    Drug Metab Dispos; 2008 Nov; 36(11):2244-51. PubMed ID: 18719239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug.
    Wong CG; Chan KF; Gibson KM; Snead OC
    Toxicol Rev; 2004; 23(1):3-20. PubMed ID: 15298489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Neurobiological Mechanisms of Gamma-Hydroxybutyrate Dependence and Withdrawal and Their Clinical Relevance: A Review.
    Kamal RM; van Noorden MS; Franzek E; Dijkstra BA; Loonen AJ; De Jong CA
    Neuropsychobiology; 2016; 73(2):65-80. PubMed ID: 27003176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
    Moitroux A; Kestens C
    Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.